Spironolactone and altizide versus converting enzyme inhibitor (enalapril)

This publication has 12 references indexed in Scilit:

• Efficacy and tolerance of spironolactone in essential hypertension
  The American Journal of Cardiology, 1987
• ENALAPRIL, ATENOLOL, AND HYDROCHLOROTHIAZIDE IN MILD TO MODERATE HYPERTENSION
  The Lancet, 1986
• Propranolol or hydrochlorothiazide alone for the initial treatment of hypertension. IV. Effect on plasma glucose and glucose tolerance. Veterans Administration Cooperative Study Group on Antihypertensive Agents.
  Hypertension, 1985
• Cardiovascular Risk and Risk Factors in a Randomized Trial of Treatment Based on the Beta-Blocker Oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH)
  Journal Of Hypertension, 1985
• MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.
  BMJ, 1985
• MORTALITY AND MORBIDITY RESULTS FROM THE EUROPEAN WORKING PARTY ON HIGH BLOOD PRESSURE IN THE ELDERLY TRIAL*1, *2
  The Lancet, 1985
• ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421".
  The Lancet, 1981
• BETA-BLOCKERS OR DIURETICS IN HYPERTENSION? A SIX YEAR FOLLOW-UP OF BLOOD PRESSURE AND METABOLIC SIDE EFFECTS
  The Lancet, 1981
• Treatment of mild hypertension: A five year controlled drug trial
  The American Journal of Medicine, 1980
• Clinical and biochemical effects of spironolactone administered once daily in primary hypertension. Multicenter Sweden study.
  Hypertension, 1980